Paul Rothenberg, MD
Orthopaedic Surgery · Hackensack, NJNPI 1912240227
Payments from drug & device makers
Across 86 payments — averaging $246.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seapearl East, Inc$14K
- Arthrex$4K
- Smith+Nephew$2K
- Medtronic$367
- Stryker$338
- Globus Medical$243
- plus $1K from 17 others
What the payments were for
- Travel & lodging$3,50617%
- Food & beverage$3,16815%
- Education$14,50268%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seapearl East, Inc | 22 | $13,606 |
| Arthrex | 15 | $3,730 |
| Smith+Nephew | 13 | $1,658 |
| Medtronic(2 entities) | 5 | $367 |
| Stryker | 4 | $338 |
| Globus Medical(2 entities) | 2 | $243 |
| Johnson & Johnson | 4 | $192 |
| Anika Therapeutics, Inc. | 1 | $144 |
| Cook Medical LLC | 1 | $130 |
| Organogenesis Inc. | 1 | $125 |
| Amarin Pharma, Inc. | 1 | $95 |
| W. L. Gore & Associates, Inc. | 1 | $83 |
| Boston Scientific | 1 | $80 |
| Zimmer Biomet | 1 | $80 |
| Surgalign Spine Technologies, Inc. | 1 | $61 |
| Avanos Medical | 3 | $56 |
| Biocomposites Inc | 1 | $46 |
| Vertex | 3 | $45 |
| Bioventus LLC | 2 | $38 |
| Vericel Corporation | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Heraeus Medical, LLC. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AETOS Shoulder System$1,266
- XLIF$199
- ENDURANT IIS$169
- GAMMA$152
- RevoMotion$144
- Zenith$130
- PuraPly$125
- MAKO$111
- INTELLIS$102
How this compares
$21,176 in reported general payments places this provider in the 80th percentile of 587 orthopaedic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 22 | $581 |
| Meloxicam | 100 | $397 |
| Cyclobenzaprine Hcl | 23 | $166 |
| Tramadol Hcl | 27 | $120 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $112 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Hackensack
- Michael KellyHackensack$9.7M
- Oscar VazquezHackensack$810K
- Yair KissinHackensack$322K
- Thomas JohnHackensack$59K
- Mark HartzbandParamus$9.4M
- Luke AustinSewell$4.3M
- Randal BetzLawrenceville$3M
- Kenneth MontgomeryMorristown$2.7M
- Zachary PostEgg Harbor Township$1.7M
- Gregg KleinParamus$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.